HealthEquity (HQY) Projected to Post Quarterly Earnings on Tuesday

HealthEquity (NASDAQ:HQY) is expected to announce its earnings results after the market closes on Tuesday, March 18th. Analysts expect the company to announce earnings of $0.71 per share and revenue of $306.12 million for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

HealthEquity Trading Up 3.7 %

HealthEquity stock opened at $97.41 on Monday. The business has a 50-day simple moving average of $105.68 and a two-hundred day simple moving average of $95.35. The company has a market cap of $8.44 billion, a P/E ratio of 89.37, a P/E/G ratio of 1.60 and a beta of 0.62. HealthEquity has a 52-week low of $65.01 and a 52-week high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

Wall Street Analyst Weigh In

HQY has been the topic of a number of research analyst reports. Mizuho initiated coverage on HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target on the stock. Royal Bank of Canada boosted their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. Barrington Research reissued an “outperform” rating and issued a $112.00 price target on shares of HealthEquity in a report on Friday. Raymond James boosted their price target on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Tuesday, February 25th. Finally, Wells Fargo & Company boosted their price target on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $112.92.

Insiders Place Their Bets

In other news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.20% of the stock is owned by insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.